Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -43.12 | -26.57 |
| PEG Ratio (TTM) | 1.01 | -7.62 |
| P/S Ratio (TTM) | 176,909.93 | 46.05 |
| P/B Ratio (TTM) | 7.13 | 31.80 |
| P/FCF Ratio (TTM) | -43.06 | -10.19 |
| Price to 5YR AVG Earnings Ratio | N/A | -7.71 |
| Price to 5YR AVG FCF Ratio | N/A | -15.41 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -15.59% | -17.65% |
| ROE (TTM) | -15.78% | 23.80% |
| Net Profit Margin (TTM) | -409,200.94% | -505.58% |
| ROIC 5YR AVG | N/A | -7.74% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -42.72% | -37,298.83% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -46.52% | -19,643.41% | N/A |
| Cash Flow | -32.94% | -3,680.83% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 25.51 | 5.84 |
| Quick Ratio (TTM) | 25.51 | 5.62 |
| D/E Ratio (TTM) | N/A | 1.14 |
| Interest Coverage (TTM) | N/A | -8.39 |
| Piotroski F-Score | 2 | 4 |
| Altman Z-Score | 92.36 | 13.46 |
| LTL to 5YR AVG FCF | N/A | 0.03 |
| Shares Outstanding Growth 5YR AVG | N/A | 40.81% |